Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Wedbush: Predicts Nasdaq will challenge the 30,000 mark in the coming year, recommends deploying investments across the entire AI industry chain

Wedbush: Predicts Nasdaq will challenge the 30,000 mark in the coming year, recommends deploying investments across the entire AI industry chain

格隆汇格隆汇2026/05/12 01:45
Show original
Glonghui, May 12 — Wedbush analyst Dan Ives predicts that the Nasdaq Composite Index will challenge the 30,000 mark within the next year, as tech companies' earnings surpass expectations and boost confidence in the AI sector. He emphasized that the current supply-demand gap for chips is as high as 10 times, and the AI revolution is still in its early stages, expressing optimism that this bull market will continue for another two years. Ives recommends that investors should arrange their portfolios across the entire AI industry chain, including major cloud giants, chips, software, network security, and electricity sectors, rather than betting solely on a single segment. He specifically highlighted memory giants such as SK Hynix, stating that the industry is currently in a super business cycle.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy

Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.

智通财经•2026/10/12 23:31

BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

智通财经•2026/10/12 23:27
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review

Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).

智通财经•2026/10/12 23:11